Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program.
Vitale A, Mastrantoni L, Russo J, Giacomini F, Giannarelli D, Duranti S, Vita E, Nero C, D'Argento E, Pasciuto T, Giacò L, Di Salvatore M, Panfili A, Stefani A, Cancellieri A, Lococo F, De Paolis E, Livi V, Daniele G, Trisolini R, Minucci A, Margaritora S, Lorusso D, Normanno N, Scambia G, Tortora G, Bria E. Vitale A, et al. Among authors: daniele g. JCO Precis Oncol. 2024 Oct;8:e2400297. doi: 10.1200/PO.24.00297. Epub 2024 Oct 7. JCO Precis Oncol. 2024. PMID: 39374480
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer.
Pietragalla A, Duranti S, Daniele G, Nero C, Ciccarone F, Lorusso D, Fagotti A, Scambia G. Pietragalla A, et al. Among authors: daniele g. Expert Opin Investig Drugs. 2021 Feb;30(2):103-110. doi: 10.1080/13543784.2021.1868436. Epub 2021 Jan 11. Expert Opin Investig Drugs. 2021. PMID: 33423551 Review.
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives.
Costanzo R, Montanino A, Di Maio M, Piccirillo MC, Sandomenico C, Giordano P, Daniele G, Franco R, Perrone F, Rocco G, Normanno N, Morabito A. Costanzo R, et al. Among authors: daniele g. Expert Rev Anticancer Ther. 2013 Oct;13(10):1207-18. doi: 10.1586/14737140.2013.845092. Expert Rev Anticancer Ther. 2013. PMID: 24134422 Review.
Integration of PARP-inhibitors in ovarian cancer therapy.
Pietragalla A, Ciccarone F, Nero C, Scambia G, Lorusso D, Daniele G. Pietragalla A, et al. Among authors: daniele g. Explor Target Antitumor Ther. 2020;1(3):171-182. doi: 10.37349/etat.2020.00011. Epub 2020 Jun 29. Explor Target Antitumor Ther. 2020. PMID: 36046198 Free PMC article. Review.
281 results